marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Forte Biosciences Financial Ratios 2011-2024 | FBRX
Annual Financial Ratios Forte Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.7 | -1.5 | -1.4 | -8.2 | -37.9 | -66.8 | -71.7 | - | - | - | - | - | - |
P/S |
- | - | - | - | - | 181.4 | 68089.2 | - | - | - | - | - | - |
EPS |
-1 | -0.8 | -1.6 | -6.3 | -1.9 | -2.4 | -2.7 | -15.2 | -10.6 | - | - | - | - |
EV (Enterprise Value) |
-13.9 M | -20.5 M | -12.2 M | 323 M | 158 M | 3.27 B | 2.78 B | 22.8 M | 14.9 M | - | - | - | - |
EBITDA per Share |
-0.89 | - | -1.54 | -1.26 | -3.03 | -33.8 | -38.3 | - | - | - | - | - | - |
EV/EBITDA |
0.7 | -22.6 | -36.4 | -72.0 | -73.9 | - | - | - | - | - | - | ||
PEG |
- | 0.01 | -0.41 | -7.93 | 1.52 | - | - | - | - | - | - | ||
P/B |
0.6 | 0.5 | 0.7 | 6.4 | -32.4 | 56.3 | 39.3 | - | - | - | - | - | - |
P/CF |
-0.8 | -2.5 | -1.8 | -20.6 | -52.6 | -89.8 | -87.8 | - | - | - | - | - | - |
ROE % |
-89.13 | -35.75 | -52.25 | -78.82 | 85.30 | -84.19 | -54.77 | - | - | - | - | - | - |
ROA % |
-80.75 | -33.05 | -50.13 | -75.91 | -53.14 | -47.49 | -42.28 | - | - | - | - | - | - |
ROCE % |
-91.99 | -35.80 | -51.71 | -24.12 | -70.75 | -52.98 | -50.34 | - | - | - | - | - | - |
Current Ratio |
- | - | - | 26.5 | 3.9 | 5.9 | 5.2 | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Forte Biosciences
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-4.54 | -0.27 | -0.16 | - | -0.26 | -0.42 | -0.32 | - | -0.18 | -0.21 | -0.17 | - | -0.54 | -0.43 | -0.36 | - | -0.45 | -9.52 | -0.97 | -0.45 | -330 | -300 | -0.74 | -0.96 | -0.02 | -0.81 | -0.65 | -0.55 | -0.5 | -0.56 | -4.11 | -3.83 | -4.09 | -3.66 | -3.64 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -0.21 | - | - | - | - | - | -0.18 | -0.2 | -0.17 | - | -0.54 | -0.42 | -0.36 | - | -0.44 | -9.51 | - | - | - | - | -0.72 | - | 0.09 | -0.76 | -0.64 | - | -0.48 | -0.52 | -3.84 | - | -3.79 | -3.41 | -3.41 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-213.87 | -148.90 | -110.89 | -80.88 | -88.82 | -72.12 | -44.31 | -22.29 | -40.05 | -49.87 | -53.57 | -38.19 | -46.83 | -37.72 | -85.01 | -71.06 | 150.85 | 173.97 | 246.12 | 238.67 | 2680.21 | 2665.08 | 2624.20 | 2612.97 | -65.73 | -79.07 | -64.15 | -54.77 | -32.74 | -11.51 | 7.71 | 26.91 | 20.13 | 12.90 | 6.43 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-138.70 | -112.73 | -93.29 | -67.72 | -75.25 | -61.99 | -41.11 | -21.39 | -37.75 | -46.57 | -49.92 | -35.76 | -44.09 | -36.06 | -81.84 | -68.44 | -206.63 | -207.32 | -158.78 | -159.64 | -40.46 | -31.82 | -39.20 | -47.49 | -40.24 | -50.68 | -44.92 | -42.28 | -54.36 | -69.01 | -81.91 | -94.70 | -70.86 | -45.40 | -22.65 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-220.19 | -153.34 | -114.07 | -82.39 | -90.38 | -73.09 | -44.69 | -22.17 | -39.81 | -49.46 | -53.07 | -37.82 | -46.31 | -37.16 | -84.57 | -70.85 | -56.51 | -33.68 | 38.44 | -127.99 | -125.54 | -137.42 | -176.97 | -46.00 | -59.70 | -75.85 | -61.66 | -37.90 | -31.05 | -10.49 | 7.81 | 19.06 | 19.06 | 12.21 | 6.08 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3.7 | 0.4 | 0.1 | 0.2 | 0.6 | 2.3 | 2.3 | 2.3 | 2.3 | 4.4 | 4.4 | 4.4 | 4.4 | 1.2 | 1.2 | 1.2 | 1.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency